Stay updated on Mylan Insulin Glargine Safety Clinical Trial
Sign up to get notified when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.

Latest updates to the Mylan Insulin Glargine Safety Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.2 was added. The previous revision (v3.4.1) with funding and operating-status notices was removed.SummaryDifference0.3%

- Check83 days agoChange DetectedA government funding notice was added and the revision version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check90 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to Mylan Insulin Glargine Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mylan Insulin Glargine Safety Clinical Trial page.